Top Corporate news of the day - September 16, 2015

Check out the most important news stories which captured the headlines at the corporate level in India and internationally.

National Aluminium Co said that the ministry of coal has allotted Utkal -D & E coal mines located in Odisha in favour of the company for it to be able to meet its captive requirements at the Angul district. 

A total of 16 stranded gas-based power plants including the likes of GMR, GVK,Lanco and NTPC will be eligible for Rs15.9bn of Government subsidy for running their plants at 50% plant load factor on imported natural gas or re-gasified liquefied natural gas (RLNG). 

Biocon has opened a manufacturing facility to make devices for its insulin portfolio. The 100,000 square feet new devices facility will make pen-like devices that diabetes patients can use for their insulin needs. 

Tata Motors is planning to open three new assembly plants for its medium and small trucks this year. Tata Motors will be opening new assembly plants in Nigeria, Mauritius, Vietnam this year. The company will be spending around Rs1.2-1.5bn in the process. 

ABB has won orders worth around Rs1.19bn to provide plant electrification, automation and substation solutions for solar power plants. Spread across Karnataka, Tamil Nadu and Andhra Pradesh, these projects will connect over 850 megawatts (MW) of solar energy to the grid and will be among the biggest solar projects worldwide. 

ONGC may bid for some of the smaller fields it earlier surrendered as unviable following the unveiling of a new government policy to develop marginal oil and gas blocks. 

Tata Motors-owned Jaguar Land Rover (JLR) has entered the SUV market with the launch of F-Pace model here which is expected to hit the Indian market in the second half of 2016. 

Leading diagnostic chain Dr Lal PathLabs is planning to go public and has filed draft papers with market regulator Sebi to raise funds through an IPO. 

Jubilant DraxImage Inc, a wholly-owned subsidiary of Jubilant Life Sciences Ltd, entered into an agreement with the Australia-based Cyclopharm Limited granting DraxImage an exclusive license to market and distribute Technegas in the US. 

Orchid Chemicals and Pharmaceuticals Ltd is planning to convert most its Rupee term loans of over Rs15bn into foreign currency loans, in order to save the higher interest paid at present.